In Brief: Pharmacia & Upjohn
This article was originally published in The Tan Sheet
Executive Summary
Pharmacia & Upjohn: Tim Rothwell to exec VP and president of pharmaceutical operations, from Rhone-Poulenc Rorer, where he held the comparable position. Rothwell will rationalize P&U's pharmaceutical operations, a job he also undertook at RPR. Additionally, Exec VP and Chief Financial Officer Robert Salisbury announces his intention to resign...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning